RECRUITING

SMYLS Multi-site Trial

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to find out whether a web-based intervention using a mobile app is helpful for teens and young adults with sickle cell disease (SCD) in learning how to care for and manage their symptoms.

Official Title

Self-Management for Youth Living With Sickle Cell Disease: SMYLS Multi-site Trial

Quick Facts

Study Start:2024-04-04
Study Completion:2028-01-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06035939

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:14 Years to 21 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * documentation in the electronic health record of any type of SCD
  2. * owns mobile device compatible with the intervention
  3. * access to the internet
  1. * Plans to relocate outside of study site area in the next 12 months
  2. * Plans to transition to adult care in 12 months or less
  3. * Parent/caregiver or provider report of neurocognitive impairment that precludes ability to use intervention and participate in study
  4. * non-English speaking

Contacts and Locations

Study Contact

Shannon Phillips, PhD, RN
CONTACT
843-792-9379
phillipss@musc.edu
Margie Prentice, MBA
CONTACT
843-792-4771
prenticm@musc.edu

Study Locations (Sites)

Medical University of South Carolina
Charleston, South Carolina, 29425
United States

Collaborators and Investigators

Sponsor: Medical University of South Carolina

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-04
Study Completion Date2028-01-31

Study Record Updates

Study Start Date2024-04-04
Study Completion Date2028-01-31

Terms related to this study

Additional Relevant MeSH Terms

  • Sickle Cell Disease